Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Vinorelbine tartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for vinorelbine tartrate and what is the scope of vinorelbine tartrate patent protection?

Vinorelbine tartrate
is the generic ingredient in two branded drugs marketed by Jiangsu Hansoh Pharm, Ebewe Pharma, Actavis Totowa, Dr Reddys Labs Ltd, Hospira, Teva Pharms Usa, Mylan Labs Ltd, Fresenius Kabi Usa, West-ward Pharms Int, and Pierre Fabre, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for vinorelbine tartrate. Eight suppliers are listed for this compound.

Summary for Generic Name: vinorelbine tartrate

Drug Master File Entries: see list14
Suppliers / Packagers: see list8
Bulk Api Vendors: see list47
Clinical Trials: see list174
Patent Applications: see list7,547
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:vinorelbine tartrate at DailyMed

Pharmacology for Ingredient: vinorelbine tartrate

Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa
vinorelbine tartrate
INJECTABLE;INJECTION076849-001Apr 18, 2005APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
vinorelbine tartrate
INJECTABLE;INJECTION076028-001Feb 3, 2003APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
vinorelbine tartrate
INJECTABLE;INJECTION202017-001Sep 12, 2013APRXNoNo► Subscribe► Subscribe
Pierre Fabre
vinorelbine tartrate
INJECTABLE;INJECTION020388-001Dec 23, 1994APRXYesYes► Subscribe► Subscribe
vinorelbine tartrate
INJECTABLE;INJECTION076827-001Jun 2, 2005APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus